Why Patient-Centric Healthcare Changes Life Sciences' Role
By Hilary Thomas, Guest Columnist, Life Science Leader
The life sciences industry – and pharma in particular – is moving from a Business-to-Business to more of a Business-to-Consumer model for many medicines – where the patient and their family is the consumer. This reflects the shift toward more personalized medicines and greater autonomy for patients which has been further accelerated during the pandemic. More virtual appointments, the unmanageable pressure on healthcare systems, and demographics all mean that enabling patients to self-manage or be treated in or closer to home is key. But for this to happen at scale the life sciences industry needs to be part of the solution. In this article we discuss the healthcare changes brought about by the pandemic, and how life sciences organizations need to respond.
PATIENT EDUCATION AND INFORMATION
Over the past 2 years or so some key players in the industry have become household names, and their brands well known. Public awareness of these companies is unheralded and consequently their research, discoveries and products are now under greater public scrutiny than ever before. To respond to the pandemic, governments needed to create accessible material
